Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  NeuBase Therapeutics, Inc.    NBSE

NEUBASE THERAPEUTICS, INC.

(NBSE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on NEUBASE THERAPEUTICS, INC.
01/14/21 FY 2020 Earnings Release (Projected)
04/01/21 Q1 2021 Earnings Release (Projected)
05/20/21 Interim 2021 Earnings Release (Projected)
Past events on NEUBASE THERAPEUTICS, INC.
10/05/20 | 11:30am Chardan Genetic Medicines Conference
09/25/20 | 04:00pm Myotonic Dystrophy Foundation Virtual Conference
09/23/20 | 10:00am Oppenheimer Healthcare Fall Summit
09/16/20 | 01:30pm H.C. Wainwright & Co., LLC Global Investment Conference
Upcoming sector events for NEUBASE THERAPEUTICS, INC.
10/24/20 | 10:40pm EXELIXIS, INC. : EORTC-NCI-AACR Symposium - Abstract No. - 170
10/25/20 | 04:25pm MIRATI THERAPEUTICS, INC. : Eortc-nci-aacr international virtual conference - presentation number: lba-03
10/25/20 | 08:20pm MIRATI THERAPEUTICS, INC. : Eortc-nci-aacr international virtual conference - presentation number: lba-04
10/25/20 | 09:30pm MIRATI THERAPEUTICS, INC. : EORTC-NCI-AACR International Virtual Conference
More events
Past sector events for NEUBASE THERAPEUTICS, INC.
10/22/20 | 03:00pm ICON PUBLIC LIMITED COMPANY : Q3 2020 Präsentation des Ergebnisses
10/22/20 | 02:30pm ARGENX SE : Q3 2020 Präsentation des Ergebnisses
10/22/20 BIOCON LIMITED : Erstes Halbjahr 2021 Ergebnisveröffentlichung
10/22/20 ARGENX SE : Q3 2020 Ergebnisveröffentlichung
Annual publications
Annual results20192020 (e)
Sales
M $
Released
Forecast
Spread
-26,3
-5,63
-368%

-16,8
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-27,0
-5,61
-381%

-17,3
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-27,0
-5,61
-381%

-17,3
Pre-Tax Profit
(EBT)
$
Released
Forecast
Spread
-3,26
-1,28
-155%

-0,89
Announcement Date01/09/2020

Quarterly publications
Previous periodNext period
Quarterly results2019 Q32019 Q42020 Q12020 Q22020 Q32020 Q4 (e)
Sales
M $
Released
Forecast
Spread


-23,1
-2,43
-851%
-3,78
-4,63
18%
-4,36
-4,01
-8,7%
-3,82
-4,77
20%

-4,74
Operating income
(EBITDA)
M $
Released
Forecast
Spread


-23,8
-2,43
-878%
-4,51
-3,75
-20%
-4,38
-4,00
-9,3%
-3,80
-4,77
20%

-4,71
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-1,13

-23,8
-2,43
-878%
-4,50
-4,63
2,7%
-4,38
-4,00
-9,3%
-3,80
-4,77
20%

-4,71
Pre-Tax Profit
(EBT)
$
Released
Forecast
Spread
-0,40

-2,14
-0,28
-673%
-0,26
-0,36
28%
-0,26
-0,22
-17%
-0,18
-0,23
21%

-0,20
Announcement Date08/14/201901/09/202003/26/202005/14/202008/13/2020

Financial data source
© 2020 S&P Global Market Intelligence
© 2020 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise